Document Detail


Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, prevents hypertensive vascular hypertrophy and fibrosis.
MedLine Citation:
PMID:  21148758     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Thromboxane A2 and other eicosanoids such as isoprostanes, binding to the thromboxane/prostaglandin endoperoxide receptors (TPr), contribute to vascular proliferation and atherosclerosis. The effects of terutroban, a TPr antagonist, were evaluated on aorta remodelling, in spontaneously hypertensive stroke-prone rats (SHRSPs), a model of severe hypertension, endothelial dysfunction, vascular inflammation and cerebrovascular diseases. Male SHRSPs were allocated to three groups receiving standard diet (n=5), high-sodium permissive-diet plus vehicle (n=6) or plus terutroban (30 mg/kg/day; n=6). After six weeks of dietary treatment, all the animals were injected with bromodeoxyuridine (BrdU) and simultaneously euthanized for aorta collection. The aortic media thickness/lumen ratio significantly (p<0.0001) increased in salt-loaded rats compared with the standard diet-fed rats, while terutroban treatment completely prevented media thickening (p<0.001). Compared with vehicle, terutroban was also effective in preventing cell proliferation in the media, as indicated by a reduced number of BrdU positive (p<0.0001) and proliferating-cell-nuclear-antigen positive cells (p<0.0001). A severe fibrosis, characterized by a significant accumulation of collagen and fibronectin in the vascular wall, was recorded in vehicle-treated rats (p<0.01) but was completely prevented by terutroban (p<0.001). The latter also inhibits heat-shock protein (HSP)47 (p<0.01) and transforming growth factor (TGF)-1β expression (p<0.001) that were significantly increased by high-salt diet. In conclusion, terutroban prevents the development of aorta hyperplasia besides exerting a benefit on fibrotic processes via an effect on TGF-beta and HSP-47 expression in SHRSP. These findings provide mechanistic data to support the beneficial effects exerted by terutroban in preventing or retarding atherogenesis.
Authors:
Paolo Gelosa; Gulnur Sevin; Alice Pignieri; Silvia Budelli; Laura Castiglioni; Vanessa Blanc-Guillemaud; Laurence Lerond; Elena Tremoli; Luigi Sironi
Related Documents :
16156208 - Nutritive values of corn, soybean meal, canola meal, and peas for broiler chickens as a...
9270138 - Comparison of fullfat soybean, sunflower seed and protected fat as fat supplements for ...
11374548 - Apparent ileal digestibility of amino acids and the digestible and metabolizable energy...
8881588 - Influence of the nature of carbohydrate intake on the absorption chronology of reducing...
3042938 - Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: compari...
19439618 - Loss of ovarian function in the vcd mouse-model of menopause leads to insulin resistanc...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2010-12-10
Journal Detail:
Title:  American journal of physiology. Heart and circulatory physiology     Volume:  -     ISSN:  1522-1539     ISO Abbreviation:  -     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-12-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100901228     Medline TA:  Am J Physiol Heart Circ Physiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
1University of Milan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Metformin and the Incidence of Prostate Cancer in Patients with Type 2 Diabetes.
Next Document:  Relative roles of doxycycline and cation chelation in endothelial glycan shedding and adhesion of le...